Biochem/physiol Actions
Tosedostat (CHR-2797) is a potent cell permeable, antiproliferative aminopeptidase inhibitor. It has been in clinical trials for AML, pancreatic cancer and more.
This product has met the following criteria to qualify for the following awards: